Apixaban for the Secondary prevention of Thromboembolism: a prospective, randomized, outcome pilot study amount patients with AntiphosPholipid Syndrome (ASTRO-APS)

Administered By

Awarded By

Contributors

Start/End

  • February 27, 2019 - December 17, 2019